Dr Eleftheria Hatzimichael
Current affiliation: University Hospital of Ioannina
Subject: Medicine And Medical Sciences
Primary location: Greece
Hematopoietic stem cell transplantation
Published in:Stem Cells and Cloning Advances and Applications
Publication date:2010-08-01
MEG3 imprinted gene contribution in tumorigenesis
Published in:International Journal of Cancer
Publication date:2011-05-05
The genomics of new drugs in sickle cell disease
Published in:Pharmacogenomics
Publication date:2006-09-01
Methylation Changes in Neoplasia
Published in:Cancer Epigenetics
Publication date:2008-09-19Diagnostic and Therapeutic Implications
Cancer Epigenetics: New Therapies and New Challenges
Published in:Journal of Drug Delivery
Publication date:2013-01-01
Treatment of β-Thalassemia Patients with Recombinant Human Erythropoietin: Effect on Transfusion Requirements and Soluble Adhesion Molecules
Published in:Acta Haematologica
Publication date:2004-01-01
Serum beta-2-microglobulin, TNF-α and interleukins in myeloproliferative disorders
Published in:European Journal Of Haematology
Publication date:2009-04-24
A Patient with Multiple Myeloma, Amyloidosis and Light-Chain Deposition Disease in Kidneys with a Long Survival
Published in:Acta Haematologica
Publication date:1999-01-01
Promoter Hypermethylation of the MEG3 (DLK1/MEG3) Imprinted Gene in Multiple Myeloma
Published in:Clinical Lymphoma & Myeloma
Publication date:2008-06-01
Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative dis...
Published in:Hematology
Publication date:2007-12-01
C-Reactive Protein and Vascular Cell Adhesion Molecule-1 as Markers of Severity in Sickle Cell Disease
Published in:Archives of Internal Medicine
Publication date:2006-02-13
Adipocytokines are related to haemolytic and inflammatory biomarkers in sickle cell beta thalassaemia
Published in:British Journal of Haematology
Publication date:2013-07-09
Host Pharmacogenetics in the Treatment of HIV and Cancer
Published in:Current Drug Safety
Publication date:2006-01-01
Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry Approaches
Published in:Molecules
Publication date:2011-05-27
Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone
Published in:European Journal Of Haematology
Publication date:2001-07-01
Alpha-2-Macroglobulin and Interleukin-6 Levels in Steady-State Sickle Cell Disease Patients
Published in:Acta Haematologica
Publication date:2000-01-01
Study of specific genetic and epigenetic variables in multiple myeloma
Published in:Leukemia & Lymphoma
Publication date:2010-11-11
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient
Published in:Leukemia Research
Publication date:2007-01-01
Combination therapy with interferon-alpha-2b and hydroxyurea in patients with chronic myelogenous leukemia
Published in:European Journal of Internal Medicine
Publication date:1999-05-01
Polycomb group proteins and MYC: the cancer connection
Published in:Cellular and Molecular Life Sciences
Publication date:2013-07-30
Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in c...
Published in:Supportive Care in Cancer
Publication date:2012-04-27
Delta-Like Homologue 1 and Its Role in the Bone Marrow Niche and Hematologic Malignancies
Published in:Clinical Lymphoma Myeloma & Leukemia
Publication date:2014-12-01
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
Published in:European Journal Of Haematology
Publication date:2010-01-01EGLN3 methylation in plasma cell neoplasia
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms
Published in:British Journal of Haematology
Publication date:2008-05-01
Prolonged interferon-alpha-2b treatment of hairy cell leukemia patients
Published in:European Journal Of Haematology
Publication date:2000-05-01
Serum Adipocytokine and Vascular Inflammation Marker Levels in Beta-Thalassaemia Major Patients
Published in:Acta Haematologica
Publication date:2010-01-01
Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes
Published in:European Journal Of Haematology
Publication date:2001-01-01
von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease
Published in:Clinical Lymphoma & Myeloma
Publication date:2009-06-01
Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenstrom's macroglobulinemia
Published in:European Journal Of Haematology
Publication date:2001-01-01
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients
Published in:Multiple Sclerosis Journal
Publication date:2005-06-01
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications
Published in:Leukemia & Lymphoma
Publication date:2012-03-13
Serum levels of soluble interleukin-2 receptor alpha (sIL-2Rα) as a predictor of outcome in brucellosis
Published in:Journal of Infection
Publication date:2005-10-01
Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases
Published in:British Journal of Haematology
Publication date:2005-09-01
Cytokine and Adhesion Molecule Expression Evolves Between the Neutrophilic and Lymphocytic Phases of Viral Meningitis
Published in:Journal of Interferon & Cytokine Research
Publication date:2010-09-01
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell n...
Published in:Leukemia Research
Publication date:2009-09-01
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes
Published in:Leukemia Research
Publication date:2010-02-01
How detection of epigenetic alterations of blood-borne DNA could improve melanoma diagnosis
Published in:Expert Review of Molecular Diagnostics
Publication date:2014-06-13
The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome
Published in:Biology Direct
Publication date:2014-01-01
Revisiting bleomycin from pathophysiology to safe clinical use
Published in:Critical Reviews in Oncology/Hematology
Publication date:2013-07-01
Non-coding RNAs and EZH2 interactions in cancer: Long and short tales from the transcriptome
Published in:International Journal of Cancer
Publication date:2012-10-17Non-coding RNAs and EZH2 Interactions in Cancer
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
Published in:Cellular and Molecular Life Sciences
Publication date:2012-07-24
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigene...
Published in:Annals of Hematology
Publication date:2011-02-22
Methylated Tissue Factor Pathway Inhibitor 2 (TFPI2) DNA in Serum Is a Biomarker of Metastatic Melanoma
Published in:Journal of Investigative Dermatology
Publication date:2013-05-01
Multiple myeloma in octogenarians: Clinical features and outcome in the novel agent era
Published in:European Journal Of Haematology
Publication date:2012-06-15
“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treat...
Published in:Annals of Hematology
Publication date:2013-07-28
Metronomic chemotherapy beyond misconceptions
Published in:Haematologica
Publication date:2013-11-01
The Rationale and Development of New Drugs to Treat HIV Infection
Published in:Medicinal Chemistry
Publication date:2005-11-01
Clinical trial design in biosimilar drug development
Published in:Investigational New Drugs
Publication date:2012-11-17
Profile of pacritinib and its potential in the treatment of hematologic disorders
Published in:Journal of Blood Medicine
Publication date:2014-08-01